1. Increased alpha cell to beta cell ratio in patients with pancreatic cancer
   Tami Tsuchiya et al, 2022, Endocrine Journal CrossRef
2. Obesity associated pancreatic ductal adenocarcinoma: Therapeutic challenges
   Mundla Srilatha et al, 2023, Seminars in Cancer Biology CrossRef
3. Advances in the Treatment of Unresectable Pancreatic Cancer
   星昊 薛, 2024, Journal of Clinical Personalized Medicine CrossRef
4. Novel Somay’s GLUCAR Index Efficiently Predicts Survival Outcomes in Locally Advanced Pancreas Cancer Patients Receiving Definitive Chemoradiotherapy: A Propensity-Score-Matched Cohort Analysis
   Erkan Topkan et al, 2024, Journal of Personalized Medicine CrossRef
5. Albumin binding revitalizes NQO1 bioactivatable drugs as novel therapeutics for pancreatic cancer
   Lei Dou et al, 2022, Journal of Controlled Release CrossRef
6. Targeting the pancreatic tumor microenvironment by plant-derived products and their nanoformulations
   Mohamed J. Saadh et al, 2024, Medical Oncology CrossRef
7. Phosphorus-32 microparticles for locally advanced pancreatic cancer: how and when?
   Luca Urso et al, 2024, Expert Review of Medical Devices CrossRef
8. Alloferon Affects the Chemosensitivity of Pancreatic Cancer by Regulating the Expression of SLC6A14
   Hyejung Jo et al, 2022, Biomedicines CrossRef
9. Accuracy of the END-PAC Model in Predicting the Risk of Developing Pancreatic Cancer in Patients with New-Onset Diabetes: A Systematic Review and Meta-Analysis
   Shahab Hajibandeh et al, 2023, Biomedicines CrossRef
10. Developments and challenges in neoadjuvant therapy for locally advanced pancreatic cancer
    Bo Zhou et al, 2023, World Journal of Gastroenterology CrossRef
11. Evolving utility of exosomes in pancreatic cancer management
    Thattungal Manoharan Anoop et al, 2023, World Journal of Methodology CrossRef